COVID-19: Toxicities of Potential Therapies

May 13, 2020 00:21:18
COVID-19: Toxicities of Potential Therapies
Critical Care Perspectives in Emergency Medicine
COVID-19: Toxicities of Potential Therapies

May 13 2020 | 00:21:18

/

Show Notes

Currently, there is no approved treatment or proven therapy for COVID-19. As such, many have turned to treatments with little to no supporting evidence. In this podcast, we bring back EM Pharmacy extraordinaire Bryan Hayes to discuss information on the toxicities of potential therapies used in the management of patients with COVID-19.

You can get CME credit for this episode here!Click here for CME Account Creation Instructions

Other Episodes

Episode 0

July 01, 2021 00:26:54
Episode Cover

The TTM2 Trial

Current international guidelines recommend TTM for adult patients with ROSC from OHCA who remain comatose or unable to follow verbal commands.  However, the overall...

Listen

Episode 0

August 28, 2020 00:25:38
Episode Cover

Ketamine in the Critically Ill

Ketamine is a well-known anesthetic used commonly in the ED for RSI and procedural sedation.  In this podcast, we review the use of ketamine...

Listen

Episode 0

August 01, 2017 00:28:45
Episode Cover

Resuscitating Under Stress!

Resuscitations are often chaotic events.  How we perform under pressure can make the difference between life and death. In this podcast we discuss a...

Listen